Percutaneous catheterization of the peritoneal cavity guided by ultrasonography in the treatment of intraabdominal carcinoma of the ovary.
The authors investigated the catheterization of the peritoneal cavity guided by ultrasound for second line chemotherapy in minimal residual intraabdominal ovarian carcinoma. They analyzed the effectiveness, patient compliance and complications of these methodology. Intraperitoneal chemotherapy used was carboplatin 200 mg/m2 dissolved in 1000 ml 5% glucose solution. After 6 course of treatment, relaparotomy was performed. Toxicity analysis shows this treatment is safe and low toxic. Only 2/11 patients developed progressive disease during treatment.
Bennedbaek
O
O
Department of Oncology, Aalborg Municipal Hospital, Denmark.
Bartholdy
N J
NJ
Fisker
P
P
Panduro
J
J
D000970:Antineoplastic Agents / Q000627:therapeutic use; D016190:Carboplatin; D002277:Carcinoma / Q000150:complications / Q000628:therapy*; D002404:Catheterization / Q000379:methods*; D005260:Female; D006801:Humans; D009944:Organoplatinum Compounds / Q000627:therapeutic use; D010051:Ovarian Neoplasms / Q000150:complications / Q000628:therapy*; D010349:Patient Compliance; D010529:Peritoneal Cavity; D014464:Ultrasonic Therapy / Q000379:methods*
D000970:Antineoplastic Agents; D009944:Organoplatinum Compounds; D016190:Carboplatin